"Building a deep tech company or building anything, pretty much, like being a founder in anything, it's like planning a bank robbery. It's like putting together a crew where, you know, you need a driver, you need someone to pick locks, you need someone to not sell, and you need someone who has the intellectual capacity to come up with a plan." In this episode of The Biotech Startups Podcast, Sergey Jakimov, Managing Partner at LongeVC, shares his journey from uncertain graduate student in Budapest to serial deep tech founder. He discusses launching his first startup at age 22 in the conservative oil and gas industry with zero experience, pioneering drug-eluting coatings for orthopedic implants, and building Lungesys—a clinical data platform that revolutionized trial patient recruitment and helped establish the world's largest biobank. Sergey challenges the "dropout culture" narrative while defending both formal education and learning by doing. He reveals why the least specialized person often makes the best founder and shares surprising truths about big pharma, including that only 14% of first-in-class cancer drugs are developed internally.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related